CDE Catalog

View and download available CureSCi CDEs using filters below. For best results, clear form between searches.

Displaying 101 - 125 of 5231
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far right side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification Version Number Version Date CRF Name ©, ® or TM Disease Name Sub Disease Name
C01559 Arterial partial pressure carbon dioxide value

Measurement of how much carbon dioxide is dissolved in the arterial blood and how well carbon dioxide is able to move out of the body (PaCO2)

Supplemental 3.00 2013-07-20 10:21:25.65 PhenX CDEs Sickle Cell Disease Sickle Cell Disease
C01559 Arterial partial pressure carbon dioxide value

Measurement of how much carbon dioxide is dissolved in the arterial blood and how well carbon dioxide is able to move out of the body (PaCO2)

Supplemental 3.00 2013-07-20 10:21:25.65 Vital Signs and Blood Gases Sickle Cell Disease Sickle Cell Disease
C01565 Blood pressure systolic measurement

Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg)

Core 3.00 2013-07-25 08:54:08.2 Renal Function Assessments Sickle Cell Disease Sickle Cell Disease
C01565 Blood pressure systolic measurement

Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg)

Core 3.00 2013-07-25 08:54:08.2 Vital Signs and Blood Gases Sickle Cell Disease Sickle Cell Disease
C01565 Blood pressure systolic measurement

Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg)

Supplemental 3.00 2013-07-25 08:54:08.2 Miscellaneous Sickle Cell-related CDEs Sickle Cell Disease Sickle Cell Disease
C01565 Blood pressure systolic measurement

Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg)

Core 3.00 2013-07-25 08:54:08.2 Cardiac MRI Sickle Cell Disease Sickle Cell Disease
C01565 Blood pressure systolic measurement

Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg)

Core 3.00 2013-07-25 08:54:08.2 Echocardiogram Sickle Cell Disease Sickle Cell Disease
C01565 Blood pressure systolic measurement

Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg)

Supplemental 3.00 2013-07-25 08:54:08.2 Selected Debaun CDEs Sickle Cell Disease Sickle Cell Disease
C01580 Temperature unit of measure

Unit of measure for the temperature numerical value

Supplemental 3.00 2013-07-24 11:38:01.2 Quantitative Sensory Testing (QST) Sickle Cell Disease Sickle Cell Disease
C01581 Weight unit of measure

Unit of measure for the weight numerical value

Supplemental 3.00 2013-07-25 08:54:08.2 Serious Adverse Events Sickle Cell Disease Sickle Cell Disease
C01582 Height unit of measure

Unit of measure for the height numerical value for subject/participant

Supplemental 3.00 2013-07-24 11:38:01.2 Serious Adverse Events Sickle Cell Disease Sickle Cell Disease
C01701 Lab specimen collection date and time

Date (and time if applicable and known) when the specimen was collected

Supplemental 3.00 2013-07-25 08:54:08.2 Selected Debaun CDEs Sickle Cell Disease Sickle Cell Disease
C01701 Lab specimen collection date and time

Date (and time if applicable and known) when the specimen was collected

Core 3.00 2013-07-25 08:54:08.2 Laboratory Tests Sickle Cell Disease Sickle Cell Disease
C01701 Lab specimen collection date and time

Date (and time if applicable and known) when the specimen was collected

Supplemental 3.00 2013-07-25 08:54:08.2 Miscellaneous Sickle Cell-related CDEs Sickle Cell Disease Sickle Cell Disease
C01701 Lab specimen collection date and time

Date (and time if applicable and known) when the specimen was collected

Proposed 3.00 2013-07-25 08:54:08.2 Hematopoiesis Form - BMTCTN 1507A Sickle Cell Disease Sickle Cell Disease
C01711 Lab test result unit of measure

Unit of measure for the laboratory test result

Proposed 3.00 2013-07-25 08:54:08.2 PhenX Toolkit: N-terminal Pro-brain Natriuretic Peptide (NT-proBNP) level Sickle Cell Disease Sickle Cell Disease
C01711 Lab test result unit of measure

Unit of measure for the laboratory test result

Core 3.00 2013-07-25 08:54:08.2 Laboratory Tests Sickle Cell Disease Sickle Cell Disease
C02200 Last study intervention date and time

Date (and time, if applicable) of the last known study intervention that the participant/subject received

Proposed 3.00 2013-07-18 16:35:19.49 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02201 Off study intervention prematurely indicator

Indicator that participant/subject discontinued study intervention before planned end of study

Proposed 3.00 2013-07-20 10:21:25.65 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02202 Off study date and time

Date (and time, if applicable and known) when participant/subject completes study or is prematurely withdrawn from study (i.e., is not being followed and will not receive intervention/treatment)

Proposed 3.00 2013-07-18 14:26:06.9 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02203 Off study reason

Primary reason participant/ subject is no longer participating in study (i.e., is not being followed and will not receive intervention/treatment).

Supplemental 3.00 2013-07-18 16:35:19.49 Miscellaneous Sickle Cell-related CDEs Sickle Cell Disease Sickle Cell Disease
C02203 Off study reason

Primary reason participant/ subject is no longer participating in study (i.e., is not being followed and will not receive intervention/treatment).

Proposed 3.00 2013-07-18 16:35:19.49 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02203 Off study reason

Primary reason participant/ subject is no longer participating in study (i.e., is not being followed and will not receive intervention/treatment).

Core 3.00 2013-07-18 16:35:19.49 Death Form Sickle Cell Disease Sickle Cell Disease
C02203 Off study reason

Primary reason participant/ subject is no longer participating in study (i.e., is not being followed and will not receive intervention/treatment).

Supplemental 3.00 2013-07-18 16:35:19.49 Selected Debaun CDEs Sickle Cell Disease Sickle Cell Disease
C02203 Off study reason

Primary reason participant/ subject is no longer participating in study (i.e., is not being followed and will not receive intervention/treatment).

Core 3.00 2013-07-18 16:35:19.49 Death Form Sickle Cell Disease Sickle Cell Disease
Displaying 101 - 125 of 5231